Tian Melissa J, Tayal Ashis H, Schlenk Elizabeth A
Questions or comments about this article may be directed to Melissa J. Tian, MSN RN CCRC, at
J Neurosci Nurs. 2015 Feb;47(1):20-6; quiz E1. doi: 10.1097/JNN.0000000000000104.
Atrial fibrillation (AF) is a frequent cause of acute ischemic stroke that results in severe neurological disability and death despite treatment with intravenous thrombolysis (intravenous recombinant tissue plasminogen activator [rtPA]). We performed a retrospective review of a single-center registry of patients treated with intravenous rtPA for stroke. The purposes of this study were to compare intravenous rtPA treated patients with stroke with and without AF to examine independent predictors of poor hospital discharge outcome (in-hospital death or hospital discharge to a skilled nursing facility, long-term acute care facility, or hospice care). A univariate analysis was performed on 144 patients receiving intravenous rtPA for stroke secondary to AF and 190 patients without AF. Characteristics that were significantly different between the two groups were age, initial National Institutes of Health Stroke Scale score, length of hospital stay, gender, hypertension, hyperlipidemia, smoking status, presence of large cerebral infarct, and hospital discharge outcome. Bivariate logistic regression analysis indicated that patients with stroke secondary to AF with a poor hospital discharge outcome had a greater likelihood of older age, higher initial National Institutes of Health Stroke Scale scores, longer length of hospital stay, intubation, and presence of large cerebral infarct compared with those with good hospital discharge outcome (discharged to home or inpatient rehabilitation or signed oneself out against medical advice). A multivariate logistic regression analysis showed that older age, longer length of hospital stay, and presence of large cerebral infarct were independent predictors of poor hospital discharge outcome. These predictors can guide nursing interventions, aid the multidisciplinary treating team with treatment decisions, and suggest future directions for research.
心房颤动(AF)是急性缺血性卒中的常见病因,尽管采用静脉溶栓治疗(静脉注射重组组织型纤溶酶原激活剂[rtPA]),仍会导致严重的神经功能残疾和死亡。我们对一个单中心接受静脉rtPA治疗卒中的患者登记系统进行了回顾性研究。本研究的目的是比较接受静脉rtPA治疗的伴有和不伴有AF的卒中患者,以检查出院结局不佳(院内死亡或出院至专业护理机构、长期急性护理机构或临终关怀机构)的独立预测因素。对144例因AF继发卒中接受静脉rtPA治疗的患者和190例不伴有AF的患者进行了单因素分析‘两组之间存在显著差异的特征包括年龄、初始美国国立卫生研究院卒中量表评分、住院时间、性别、高血压、高脂血症、吸烟状况、大脑梗死的存在以及出院结局。二元逻辑回归分析表明,与出院结局良好(出院回家或接受住院康复或自行出院)的患者相比,AF继发卒中且出院结局不佳的患者年龄更大、初始美国国立卫生研究院卒中量表评分更高、住院时间更长、需要插管以及存在大脑梗死的可能性更大。多因素逻辑回归分析显示,年龄较大、住院时间较长以及存在大脑梗死是出院结局不佳的独立预测因素。这些预测因素可指导护理干预,帮助多学科治疗团队做出治疗决策,并为未来的研究指明方向。